09 November 2020 - BEAM AllianceAntibiorésistance : Anticiper une nouvelle crise sanitaireFlorence Séjourné, présidente de BEAM Alliance : « Il faut anticiper les investissements en R&D dès maintenant pour avoir un…read more >>
28 August 2020 - BEAM AllianceBEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibioticsBEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibioticsread more >>
27 August 2020 - BEAM AllianceBEAM Alliance – Reflection paper on the AMR Action FundThe COVID-19 pandemic has stressed how drug and vaccine development requires time and resources. Whilst we welcome the launch of…read more >>
10 July 2020 - BEAM AllianceBEAM Alliance – Reflection paper on the EU Pharmaceutical Strategy RoadmapBEAM welcome the European Commission's ambition to support innovation in its upcoming Pharmaceutical Strategy. In our latest paper , we…read more >>
02 April 2020 - BEAM AllianceRequest for Proposals (RFP) for an Agreement for Performance of Work (APW) to develop an online e-learning course on antimicrobial stewardshipTo support the Antimicrobial Stewardship and Awareness (ASA) Unit in the Global Coordination and Partnership on Antimicrobial Resistance (GCP) department…read more >>
03 December 2019 - BEAM AllianceNew IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistanceThe aim of the IMI Antimicrobial Resistance (AMR) Accelerator is to progress the development of new medicines to treat or…read more >>
15 April 2024 - PHAXIAMPHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusPHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The…read more >>
09 April 2024 - BasileaBasilea awarded CARB-X grant to develop recently acquired novel class of antibioticsBasilea has been awarded a grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit partnership dedicated to supporting…read more >>
06 April 2024 - AktheliaAkthelia receives European Commission Seal of ExcellenceAkthelia Pharmaceuticals - Leading the Science of Our Surfaces™️ - is a late preclinical-stage biopharma company with a next-generation immunotherapeutic…read more >>
04 April 2024 - BasileaBasilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indicationsFDA approved ZEVTERA® (ceftobiprole medocaril sodium for injection), for the treatment of adult patients with Staphylococcus aureus bloodstream infections (bacteremia)…read more >>
05 March 2024 - BioVersys AGBioVersys and GSK successfully complete IMI2 programme reaching clinical MilestoneThe completion of the TRIC-TB public private partnership program and successful delivery through early clinical development of a new anti-TB…read more >>
20 February 2024 - AdjuTec Pharma ASAdjuTec Pharma Completes a Capital Raise of NOK 16millAdjutec has completed a capital raise of NOK 16mill to support the phase 1 program of APC148 expected to start in 2024.read more >>
25 March 20259th AMR ConferenceSave the date! The 9th AMR Conference will be organized as a face-to-face event on 25-26 February 2025, in Basel.…read more >>
04 November 2024BIO-Europe ® 2024 – 30th Annual International Partnering ConferenceOver the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering,…read more >>
23 April 2024REVIVE Webinar: Efflux inhibitors: A strategy to tackle multidrug resistanceThe next REVIVE webinar will feature an overview of bacterial efflux and how molecules designed to inhibit this can be…read more >>
18 April 2024BEAM webinar – Swiss RTA: Why do we need a pull incentive to push antibiotics onto the market?BEAM is excited to host a series of webinars setup by its Associated Organizations.read more >>
09 April 2024REVIVE Webinar: Progressing a discovery project – Criteria and challengeswith Ken Bradley, Global Head, Infectious Disease Discovery, Roche and Diarmaid Hughes, Professor of Medical Molecular Bacteriology, Uppsala University (Sweden)read more >>
21 March 2024BEAM webinar – BioAster: Novel technologies with an AI-facilitated approachBEAM is excited to host a series of webinars setup by its Associated Organizations.read more >>
18 March 2024BIO-Europe Spring ® 2024 – 18th Annual International Partnering ConferenceReconnecting and facilitating global partnershipsread more >>
06 March 20248th AMR ConferenceThe AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and…read more >>
27 February 2024GARDP Webinar – What does the future look like if pull incentives to support antibiotic R&D are insufficient?This webinar will discuss potential solutions, including support for non-profit R&D organizations, to get new treatments to patients in the…read more >>